Does Aetna cover primary hyperhidrosis (excessive sweating) telehealth in California?
Aetna Telehealth Copay in California
California's strong telehealth parity laws keep Aetna telehealth copays comparable to in-person office visits. HMO and PPO plans both covered.
Copay ranges are estimates based on published plan data (April 2026). Your exact cost depends on your specific plan. Verify at your Aetna member portal or call the number on your card before booking. Self-pay $49 flat always available.
Aetna California Coverage Policy — Primary Hyperhidrosis (Excessive Sweating)
Aetna California commercial plans cover prescription treatments for documented primary hyperhidrosis. Glycopyrronium cloth (Qbrexza) — a topical anticholinergic for axillary hyperhidrosis — requires prior authorization and step therapy on Aetna CA plans; step therapy typically requires prior trial of topical aluminum chloride (prescription-strength Drysol) first. Generic oral glycopyrrolate (1–2mg) is Tier 1 and covered without PA. Oxybutynin (generic, off-label for hyperhidrosis) is Tier 1 at $4–$10/month. Botulinum toxin (Botox) injections for primary axillary or palmar hyperhidrosis require prior authorization under Aetna Medical Policy — criteria include significant professional/social disruption AND failure of topical aluminum chloride antiperspirant. Botox for axillary hyperhidrosis that Aetna determines is primarily cosmetic in motivation is NOT covered. Sofpironium topical gel (Sofdra) is a newer topical anticholinergic; coverage varies by plan. Iontophoresis (hand/foot hyperhidrosis) is covered as medically necessary when oral pharmacotherapy has failed and topical agents are ineffective per Aetna Policy CPB 0229.
California's warm climate — particularly in the Inland Empire, Central Valley, and Southern California desert regions — exacerbates hyperhidrosis symptoms, making effective treatment especially important for patients in these regions. California's large professional and tech workforce (Silicon Valley, LA entertainment industry) has high demand for hyperhidrosis management given the functional impact on computer work and client-facing roles. Dermatology wait times in the Bay Area and Los Angeles are 3–8 weeks for new patients; telehealth provides faster access to prescription antiperspirants and oral anticholinergics that do not require in-person procedures.
Primary hyperhidrosis affects approximately 4.8% of the US population, with peak onset in adolescence and young adulthood. It significantly impairs occupational function (difficulty with keyboards, pen-holding, surgical instruments) and social quality of life. Pathophysiology involves overactivity of sympathetic cholinergic innervation to eccrine sweat glands — not a structural gland abnormality. Telehealth evaluation is appropriate for the initial prescription of topical and oral pharmacotherapy. Dr. Bhavsar assesses onset age, distribution (axillary, palmar, plantar, generalized), severity impact on daily function, prior treatment history, and screens for secondary causes (thyroid dysfunction, medication side effects, lymphoma-associated night sweats). Patients requiring Botox injections, iontophoresis device fitting, or surgical ETS are referred to in-person dermatology or neurology.
Excessive Sweating (Hyperhidrosis) Treatment Treatment & Prescriptions — What to Expect
Aluminum chloride hexahydrate 20% solution (Drysol — prescription-strength) applied nightly to dry affected area, first-line per International Hyperhidrosis Society (IHS) 2024 algorithm; glycopyrronium cloth 2.4% (Qbrexza) once daily to axillae if aluminum chloride inadequate (requires PA with step therapy documentation); oral glycopyrrolate 1mg twice daily for generalized or multi-site hyperhidrosis
Oxybutynin 2.5–5mg daily (off-label, Tier 1 generic, well-tolerated at low doses for hyperhidrosis); propranolol 10–20mg as-needed for situational/anxiety-related sweating (performance events); sofpironium 15% gel (Sofdra) once daily to axillae — newer topical with lower systemic anticholinergic burden than Qbrexza; iontophoresis device (home use, palmar/plantar) if topical therapy fails
Partially. Prescription aluminum chloride (Drysol) and generic oral glycopyrrolate are Tier 1, covered. Qbrexza requires PA + step therapy through aluminum chloride first — if approved, Tier 3 specialty ($60–$120/month). Sofpironium (Sofdra) formulary status varies by plan. Botox for hyperhidrosis requires separate medical benefit PA. Iontophoresis devices (home rental) are covered under durable medical equipment benefit with documented medical necessity.
Hyperhidrosis is classified as primary focal (axillary, palmar, plantar, craniofacial — without identifiable cause) or secondary (underlying medical condition — thyroid disease, menopause, medications, lymphoma). TDMD evaluates for secondary causes before prescribing. Secondary hyperhidrosis requires diagnosis and treatment of the underlying condition. Botox for axillary hyperhidrosis is in-office procedure (not telehealth) — TDMD prescribes oral/topical medications and refers for Botox evaluation if needed. Cosmetic motivation for Botox (wanting less sweat for aesthetic reasons without documented functional impairment) is explicitly not covered by Aetna.
Video assessment of hyperhidrosis distribution, severity (Hyperhidrosis Disease Severity Scale or functional impact description), onset pattern, and bilateral symmetry (characteristic of primary). Secondary cause screen: thyroid function history, medication review, fever/weight loss/night sweats (lymphoma screen). Assessment of prior treatment response to OTC antiperspirants and lifestyle modifications.
How to Get Primary Hyperhidrosis (Excessive Sweating) Treatment Using Aetna in California
Book Your Visit Online
Go to teledirectmd.com/book-online. Select "Insurance" as your payment method. Have your Aetna member ID card ready — we verify your coverage before your visit.
Coverage Verified for You
We confirm your Aetna benefits before you join the video call. If your specific plan isn't in-network, we'll let you know so you can choose self-pay ($49) instead.
Video Visit with Dr. Bhavsar, MD
Connect by secure video from your phone, tablet, or computer. Dr. Bhavsar evaluates your symptoms — same clinical standard as an in-person visit, not a PA or NP.
Prescription Sent Instantly
If a prescription is appropriate, it's sent electronically to your preferred pharmacy the moment your visit ends. Your pharmacy benefit applies to the medication.
What Actually Happens During Your Visit
Your Aetna member ID card, a list of current medications, your pharmacy name and zip code, and 5–10 minutes of quiet time. Your phone's camera needs to be working — that's it.
A secure, HIPAA-compliant video window opens. You'll see Dr. Bhavsar, MD — not a bot, not a PA. The average visit runs 8–12 minutes. He'll ask about your symptoms, review your history, and ask follow-up questions.
For Excessive Sweating (Hyperhidrosis) Treatment: Dr. Bhavsar uses validated clinical criteria — not a generic symptom checklist — to assess your presentation, rule out red flags that require in-person care, and determine whether a prescription is appropriate.
If a prescription is clinically appropriate, it is sent electronically to your preferred pharmacy before the video call ends. Most pharmacies fill it within 1–2 hours. You'll also receive a visit summary.
Aetna receives the claim automatically — billing codes 99213 or 99214 depending on visit complexity. Your Aetna Explanation of Benefits (EOB) arrives within 2–4 weeks showing what was billed and your cost.
Frequently Asked Questions — Aetna + Excessive Sweating (Hyperhidrosis) Treatment in California
Other Aetna Conditions Covered in California
State Insurance Authority: If you have a complaint or question about insurance coverage in California, contact the California Department of Insurance.
Or pay $49 cash — see the full pricing breakdown across every care setting (TeleDirectMD vs. ER, urgent care, retail clinic, and other telehealth platforms).
Compare TeleDirectMD to Other Telehealth Providers
Or pay $49 cash — see how TeleDirectMD\'s flat rate stacks up against the major US telehealth platforms. Side-by-side, with sources.
Insurance coverage and plan acceptance are subject to change. Information reflects active contracts as of April 2026 and is verified monthly. Not all plans from a listed insurer may be accepted — Medicaid and Medicare fee-for-service plans are not accepted unless specifically noted. Copay estimates are based on published plan data and may not reflect your exact cost. Patients should verify benefits with their insurer before booking. TeleDirectMD does not guarantee insurance coverage for any specific service. Dr. Parth Bhavsar, MD · NPI: 1104323203 · Board-Certified Family Medicine · Contact: contact@teledirectmd.com.
